Structure of important neurotransmitter regulator determinedFebruary 04, 2008
The enzyme is human kynurenine aminotransferase II (KAT II), which regulates the activity of the neurotransmitter system that is activated by glutamate, the most common neurotransmitter in the brain.
Qian Han, a research scientists in biochemistry at Virginia Tech; Howard Robinson, a biologist at Brookhaven; and Jianyong Li, associate professor of biochemistry at Virginia Tech, report their findings in the article, "Crystal structure of human kynurenine aminotransferase II," in the Feb. 8 issue of the Journal of Biological Chemistry (www.jbc.org/).
Li, who is corresponding author, explained that learning and memory depend upon glutamate; however, over stimulation will lead to neuron death and is one cause of such neurodegenerative diseases Parkinson's and Alzheimer's.
"The product of KAT II is kynurenic acid (KA) that is a noncompeting binder of the glutamate receptors. Its binding to the glutamate receptors reduces stimulation. So it (KA) has a regulatory effect," Li said. "It is considered protective - although too much is also a problem," he said.
Before scientists can target KAT II as a treatment, they have to know how it works. Part of the challenge was solved when the DNA sequence of KAT II was determined, but knowing the code is not enough. How proteins pass their critical messages also depends upon their shape. Imagine proteins as curls of ribbons with each unique fold as important to the messages they convey as the sequences of letters in their genetic code.
Han, Robinson, and Li succeeded in determining both the unbound protein and its complex three-dimensional structures of KAT II. The structure in complex with kynurenine reveals the almost ephemeral linkages of the KAT II enzyme with its substrate.
"Now we know what it looks like, we can determine how it works and do research into how to manipulate the protein," Li said. "We have provided a molecular basis for biochemical regulation of this critical regulator."
The article reports on Han's research to crystallize KAT II in combination with a substrate. Robinson used a synchrotron to create X-ray diffraction patterns to reveal atomic and molecular associations within the crystal, which allowed Han and Li to do phase determination and an iterative process of model building and refinement and eventually describe the structure.
Related Neurotransmitter Current Events and Neurotransmitter News Articles
Early life stress may cause excess serotonin release resulting in a serotonin deficit
Studies indicate that the majority of people with mood and anxiety disorders who receive the most commonly prescribed class of antidepressant medications, Selective Serotonin Reuptake Inhibitors or SSRI's, are not helped by these medications.
Joslin scientists find direct link between insulin resistance and behavioral disorders
People with diabetes are more prone to anxiety and depression than those with other chronic diseases that require similar levels of management. The reasons for this aren't well understood, but Joslin Diabetes Center researchers have discovered one potential explanation.
Reviving drugs with anti-stroke potential, minus side effects
In the 1990s, neuroscientists identified a class of drugs that showed promise in the area of stroke. NMDA receptor antagonists could limit damage to the brain in animal models of stroke.
Anticholinergic drugs linked to risk for pneumonia in elderly
Taking commonly used medications with anticholinergic effects is associated with a significantly higher risk for developing pneumonia in a study of more than 3,000 older Group Health patients living in the community--not in nursing homes.
Altering perception of feeding state may promote healthy aging
Targeting mechanisms in the central nervous system that sense energy generated by nutrients might yield the beneficial effects of low-calorie diets on healthy aging without the need to alter food intake, suggests new research from Harvard T.H. Chan School of Public Health.
An evolutionary approach reveals new clues toward understanding the roots of schizophrenia
Is mental illness simply the evolutionary toll humans have to pay in return for our unique and superior cognitive abilities when compared to all other species?
Protein linked to longevity and enhanced cognition protects against Alzheimer's symptoms
Scientists from the Gladstone Institutes and the University of California, San Francisco report in the Journal of Neuroscience that raising levels of the life-extending protein klotho can protect against learning and memory deficits in a mouse model of Alzheimer's disease.
Napping reverses health effects of poor sleep
A short nap can help relieve stress and bolster the immune systems of men who slept only two hours the previous night, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
New therapeutic principle for Parkinsonian dyskinesia shows clinical effect
Involuntary dyskinetic movements induced by treatment with levodopa (L-dopa) are a common problem for people with Parkinson's disease.
MGH/MIT study identifies neurons important for induction of natural REM sleep
Researchers at Massachusetts General Hospital (MGH) and Massachusetts Institute of Technology (MIT) have added another piece to the complex puzzle of how the brain controls one of the most essential functions - sleep.
More Neurotransmitter Current Events and Neurotransmitter News Articles